Prognostic Model of Stage II Non-Small Cell Lung Cancer by a Discriminant Analysis of the Immunohistochemical Protein Expression

Author： Kohri Takayuki Sugano Masayuki Kawashima Osamu Saito Ryusei Sakurai Shinji Sano Takaaki Nakajima Takashi

Publisher： Springer Publishing Company

ISSN： 0941-1291

Source： Surgery Today, Vol.36, Iss.12, 2006-12, pp. : 1039-1046

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer

By Cheng Y.-L. Lee S.-C. Harn H.-J. Chen C.-J. Chang Y.-C. Chen J.-C. Yu C.-P.

European Journal of Cardio-Thoracic Surgery, Vol. 23, Iss. 2, 2003-02 ,pp. : 221-228

Elsevier

Access to resources Recommend Favorite

Prognostic significance of E-cadherin and -catenin in resected stage I non-small cell lung cancer

By Soo Choi Y. Mog Shim Y. Kim S.-H. Soon Son D. Lee H.-S. Young Kim G. Han J. Kim J.

European Journal of Cardio-Thoracic Surgery, Vol. 24, Iss. 3, 2003-09 ,pp. : 441-449

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Lymphovascular Invasion for Patients with Stage I Non-Small Cell Lung Cancer

European Surgical Research, Vol. 47, Iss. 4, 2011-10 ,pp. : 211-217

Karger

Access to resources Recommend Favorite

Prognostic value of visceral pleura invasion in non-small cell lung cancer

By Kang J.-H. Kim K.D. Chung K.Y.

European Journal of Cardio-Thoracic Surgery, Vol. 23, Iss. 6, 2003-06 ,pp. : 865-869

Elsevier

Access to resources Recommend Favorite

Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study

By Sienel W. Varwerk C. Linder A. Kaiser D. Teschner M. Delire M. Stamatis G. Passlick B.

European Journal of Cardio-Thoracic Surgery, Vol. 25, Iss. 1, 2004-01 ,pp. : 131-134

Elsevier

Access to resources Recommend Favorite